J Sastry1, S S Karandikar, M W E English. Show Affiliations » 1. Department of Pediatric Oncology, Llandough Hospital, Cardiff, UK.
Abstract
Entities: Disease
Mesh： See more » Acetazolamide/therapeutic useAdolescentAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useAsparaginase/administration & dosageAsparaginase/therapeutic useChlorthalidone/therapeutic useCyclophosphamide/administration & dosageCyclophosphamide/therapeutic useCytarabine/administration & dosageCytarabine/adverse effectsCytarabine/therapeutic useDaunorubicin/administration & dosageDaunorubicin/therapeutic useDiagnosis, DifferentialHeadache/etiologyHumansIntracranial Hypertension/diagnosisIntracranial Hypertension/drug therapyIntracranial Hypertension/etiologyMaleMercaptopurine/administration & dosageMercaptopurine/therapeutic useMethotrexate/administration & dosageMethotrexate/therapeutic usePrecursor Cell Lymphoblastic Leukemia-Lymphoma/complicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyPrednisolone/administration & dosagePrednisolone/therapeutic useSinus Thrombosis, Intracranial/diagnosisVincristine/administration & dosageVincristine/therapeutic useVomiting/etiology
Substances： See more » CytarabineVincristineCyclophosphamidePrednisoloneMercaptopurineAsparaginaseAcetazolamideChlorthalidoneMethotrexateDaunorubicin
Year: 2003 PMID： 12554527 DOI： 10.1080/0880010390158667
Source DB: PubMed Journal: Pediatr Hematol Oncol ISSN： 0888-0018 Impact factor: 1.969